All Products
Also known as
NEVA, Nocturnal Electrobioimpedance Volumetric Assessment, Electrobioimpedance Penile Assessment, Nocturnal Penile Electrobioimpedance
Definition
Nocturnal Electrobioimpedance Volumetric Assessment (NEVA) is a diagnostic procedure that measures penile volume changes during nocturnal erections for erectile dysfunction (ED) assessment1. The technique is based on the principle of delivering a constant, nondetectable alternating current to penile tissue and measuring the resulting impedance changes, which correlate with blood volume changes during erections2. From these measurements, penile length, cross-sectional area, and volume can be determined, allowing for the calculation of the number and duration of erectile events, volume change, and percentage of volume increase from baseline3.
The NEVA device consists of three electrode sets and a small recorder. One set of electrodes is applied to the base of the penis, another set is placed subcoronally (near the glans), and a reference electrode is placed on the hip4. The recorder is worn comfortably on the upper thigh, allowing for home-based monitoring over multiple consecutive nights1.
NEVA provides objective data on nocturnal erectile function, helping clinicians differentiate between psychogenic and organic causes of erectile dysfunction3. Studies have shown that patients with ED have fewer nocturnal erectile events that result in a smaller increase in penile blood volume change over baseline compared to individuals without ED1. Additionally, NEVA can potentially distinguish between different types of organic impotence, such as arterial insufficiency and veno-occlusive dysfunction2, which is not possible with traditional nocturnal penile tumescence (NPT) monitoring4.
Clinical Context
Nocturnal Electrobioimpedance Volumetric Assessment is primarily used in the diagnostic evaluation of erectile dysfunction (ED)1. The procedure helps clinicians differentiate between psychogenic and organic causes of ED by providing objective measurements of nocturnal penile erections3. This distinction is crucial for determining appropriate treatment strategies, as psychogenic ED may respond better to psychological interventions, while organic ED often requires medical or surgical management2.
Patient selection for NEVA typically includes men with suspected ED when the etiology is unclear or when objective data is needed for insurance purposes4. The procedure is particularly valuable in cases where the distinction between psychogenic and organic causes is not evident from the patient’s history or physical examination1.
The NEVA procedure is noninvasive and can be performed in the patient’s home environment, making it a practical alternative to laboratory-based sleep studies1. Patients wear the device for typically 2-3 consecutive nights to obtain reliable data3. The data collected includes the number and duration of erectile events, as well as the percentage of volume change over baseline1.
Research has demonstrated that NEVA can potentially distinguish between different types of organic impotence, such as arterial insufficiency and veno-occlusive dysfunction2, which is not possible with traditional nocturnal penile tumescence (NPT) monitoring4. This capability allows for more targeted diagnostic follow-up and treatment planning2.
Studies have shown good correlation between NEVA measurements and other diagnostic methods such as duplex Doppler ultrasound1. In comparative studies, patients with ED had fewer nocturnal erectile events that resulted in a smaller increase in penile blood volume change over baseline compared to individuals without ED1.
Expected outcomes from NEVA testing include objective documentation of erectile function, differentiation between psychogenic and organic causes of ED, and potential insights into the specific type of organic impotence when present2. This information guides subsequent diagnostic evaluations and treatment decisions, potentially improving patient outcomes3.